article Open AccessTop 1% cited

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995

Cancer · 1998 · Vol. 83(12) · pp. 2638–2648

Scott A. Hundahl(Queen's Medical Center)Irvin D. Fleming(University of Tennessee Health Science Center)Amy M. Fremgen(American College of Surgeons)Herman R. Menck✉(American College of Surgeons)

View via DOI Full-text PDF

Abstract

The NCDB system permits analysis of care patterns and survival for large numbers of contemporaneous U. S. patients with relatively rare neoplasms, such as thyroid carcinoma. In this context, it represents an unsurpassed clinical tool for analyzing care, evaluating prognostic models, generating new hypotheses, and overcoming the volume-related drawbacks inherent in the study of such neoplasms. [See editorial on pages 2434-6, this issue.]

Thyroid Cancer Diagnosis and Treatment BRCA gene mutations in cancer Global Cancer Incidence and ScreeningMedicineCancerRelative survivalCancer registryThyroid cancerStage (stratigraphy)Lymph nodeOncologyInternal medicineSurgery

MeSH terms

AdenocarcinomaAdolescentAdultAgedAged, 80 and overCarcinomaCarcinoma, PapillaryChildChild, PreschoolHumansInfantInfant, NewbornMiddle AgedNeoplasm StagingRegistries

Citations

1,839

FWCI

13.36

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated Patients